who discovered glp 1 drugs Scientists the Glucagon Yusa peptide (GLP-1) were selected as winners of the Lasker P GLP-1 receptor assay: drug discovery

Description

Curious about Microdosing GLP-1

GLP-1 receptor agonists got their start in an unlikely place: the mouth of a lizard

Retatrutide emerges as a promising multi-pathway therapeutic, attracting significant clinical interest for its potent effects on weight loss and metabolic control

Additionally, several key clinical trial readouts delivered compelling data across multiple indications, for example (see Figure 1): Semaglutide: STEP-HFpEF (functional benefits in HFpEF), STEP-9 (pain reduction in knee osteoarthritis), STEP-10 (reversion to normoglycaemia in pre-diabetic, obese patients), ESSENCE (resolution of MASH, improvement in fibrosis) Tirzepatide: SUMMIT (risk reduction in HFpEF outcomes

Zachariah Reitano, co-founder and CEO of Ro, the direct-to-patient healthcare company, discusses the ripple effects of GLP1 medications such as Ozempic and Wegovy.